Login or sign up
For business

Protara therapeutics

4.1· 8 reviews
Average ratingGreat
4.1/ 5

Based on 8 reviews

538%
438%
325%
20%
10%
Ask AI

Questions about Protara therapeutics

Based on 8 reviews, listing data and website checks · updated 7 days ago

What is Protara therapeutics?

Protara Therapeutics is a clinical-stage biotechnology company headquartered in New York, NY, that develops transformative therapies for cancer and rare diseases. Their lead investigational cell therapy, TARA-002, is based on the broad immunopotentiator OK-432, which is approved in Japan and Taiwan for multiple oncologic indications and lymphatic malformations. They are also developing IV Choline Chloride, an investigational phospholipid substrate replacement therapy for patients on parenteral support.

What specific therapies is Protara Therapeutics developing right now?

The company is currently evaluating TARA-002 for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs) in the U.S. Additionally, they are developing IV Choline Chloride to address choline deficiency and liver damage in patients receiving parenteral support.

What regulatory designations has TARA-002 received from the FDA?

Protara Therapeutics holds FDA Rare Pediatric Disease Designation for TARA-002, which is being evaluated for NMIBC and LMs in the U.S. They have also received both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in pediatric patients with lymphatic malformations.

What do recent reviewers say about the company's website and customer service?

Some users on Reddit say the company's website is well-designed, easy to navigate, and provides all the necessary information. Reviewers also note that the products are of high quality and customer service is top-notch, with one reviewer describing the experience as fantastic and the products as top-tier.

Where is Protara Therapeutics located and how can I contact them?

Protara Therapeutics is located at 345 Park Avenue South, 3rd Floor, New York, NY 10010. Their contact phone number is +1 646-844-0337. The company also has a presence in East Village, New York.

What is in Protara Therapeutics' current development pipeline?

The company has a pipeline of investigational products including TARA-002 and IV Choline Chloride. They are actively conducting clinical trials such as the ADVANCED-2 trial for NMIBC and the THRIVE-3 Phase 2b dosing trial for IV Choline Chloride.

What is the current Trustburn rating and review count for Protara Therapeutics?

Protara Therapeutics has a Trustburn rating of 4.1 out of 5 from 8 reviews. The reviews range from 3 to 5 stars, with most being positive about the website and product quality.

What recent clinical trial updates have been reported about Protara Therapeutics?

Some users on Reddit mention that Protara Therapeutics is presenting updated interim data from the Phase 2 ADVANCED-2 trial at the ASCO Genitourinary Cancers Symposium. They also announced positive 12-month data demonstrating durable responses in the BCG-Naïve cohort of the ongoing Phase 2 ADVANCED-2 trial.

What are the upcoming milestones for Protara Therapeutics' clinical trials?

Protara Therapeutics announced that they expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial by year-end 2026. They also expect to initiate a rolling BLA submission for TARA-002 in LMs in the second half of 2027.

What financial results did Protara Therapeutics report recently?

Protara Therapeutics reported GAAP EPS of -$0.35, which beat expectations by $0.02. They also announced inducement grants under Nasdaq Listing Rule 5635(c)(4).

What recent trial completions have been announced by Protara Therapeutics?

Protara Therapeutics completed enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride. They remain on track to report interim results from the Phase 2b cohort in the fourth quarter of 2026.

What is the mission and philosophy of Protara Therapeutics?

Protara Therapeutics is committed to advancing transformative therapies for people with cancer and rare diseases. They believe in reflecting the world in which they live to truly understand and treat these conditions, which often know no boundaries of age, gender, race, religion, or socioeconomic background.

Is Protara therapeutics on social media?

Protara therapeutics has official profiles on Linkedin.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Protara therapeutics

tenacious in our search for transformative therapies LEARN ABOUT US TARA-002 TARA-002 is the Company’s lead investigational cell therapy based on the broad immunopotentiator OK-432, which is approved in Japan and Taiwan for multiple oncologic indications and lymphatic malformations (LMs). We are ...

Protara Therapeutics: Revolutionizing the Future of Healthcare

Protara Therapeutics is a biopharmaceutical company that is dedicated to discovering and developing transformative therapies for patients suffering from serious diseases. The company's mission is to improve the lives of patients by providing innovative treatments that address unmet medical needs.

Founded in 2013, Protara Therapeutics has quickly established itself as a leader in the field of biopharmaceuticals. The company's team of experienced scientists and researchers are tenacious in their search for new therapies, working tirelessly to develop groundbreaking treatments that can change the course of disease.

One such therapy is TARA-002, Protara Therapeutics' lead investigational cell therapy. TARA-002 is based on OK-432, a broad immunopotentiator that has been approved in Japan and Taiwan for multiple oncologic indications and lymphatic malformations (LMs). This innovative treatment has shown great promise in clinical trials, demonstrating significant efficacy against various types of cancer.

Protara Therapeutics' commitment to innovation extends beyond its research efforts. The company also places great emphasis on collaboration with other organizations and individuals who share its vision for improving patient outcomes. By working together with healthcare providers, academic institutions, patient advocacy groups, and other stakeholders, Protara Therapeutics aims to accelerate the development and delivery of life-changing therapies.

At Protara Therapeutics, patient-centricity is at the heart of everything we do. We understand that every patient's journey is unique, which is why we strive to develop personalized treatments that take into account each individual's specific needs. Our goal is not just to treat disease but also to improve quality-of-life outcomes for patients.

In addition to TARA-002, Protara Therapeutics has several other promising programs in its pipeline. These include PTX-100 (a novel protein therapeutic), PTX-200 (a small molecule inhibitor), and PTX-Covid19 (a potential treatment for COVID-19). Each of these programs represents a significant step forward in the fight against disease, and we are excited to continue exploring their potential.

Protara Therapeutics is committed to excellence in all aspects of its operations. From research and development to manufacturing and commercialization, the company adheres to the highest standards of quality and safety. We are proud of our achievements so far, but we know that there is still much work to be done. With our dedicated team and innovative approach, we are confident that we can make a real difference in the lives of patients around the world.

In conclusion, Protara Therapeutics is a biopharmaceutical company that is revolutionizing the future of healthcare through its commitment to innovation, collaboration, patient-centricity, and excellence. With TARA-002 as its lead investigational cell therapy and several other promising programs in its pipeline, Protara Therapeutics is poised to make a significant impact on the field of biopharmaceuticals. We invite you to join us on this exciting journey towards better health outcomes for all.

Address
1 Little West 12th St
Categories
Biotechnology